Aramark director receives 36.644 share-equivalent award

Aramark director Brian M. DelGhiaccio reported an acquisition of 36.644 shares of common stock-equivalent rights on June 3, 2026.

Rhea-AI Filing Summary

Aramark director Brian M. DelGhiaccio reported an acquisition of 36.644 shares of common stock-equivalent rights on June 3, 2026. The Form 4 describes these as dividend equivalent rights that accrued on deferred stock units he already holds, tied to Aramark’s regular quarterly dividend.

These rights were granted at no cash cost and vest on the same schedule as the underlying deferred stock unit awards. Following this award, DelGhiaccio’s direct holdings reported in this filing total 16,385.995 shares of Aramark common stock.

Insider Trade Summary

Grant/Award: 36.644 shares

Grant/Award 1 txn

Insider DelGhiaccio Brian M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	36.644	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,385.995 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Key Figures

Shares granted: 36.644 shares Post-transaction holdings: 16,385.995 shares Grant price: $0.00 per share +1 more

4 metrics

Shares granted 36.644 shares Dividend equivalent rights credited on June 3, 2026

Post-transaction holdings 16,385.995 shares Direct Aramark common stock holdings after award

Grant price $0.00 per share Reported transaction price for dividend equivalent rights

Transaction code A (Grant, award, or other acquisition) Non-derivative Form 4 transaction classification

Key Terms

dividend equivalent rights, deferred stock units, Grant, award, or other acquisition

3 terms

dividend equivalent rights financial

"Represents dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

deferred stock units financial

"accrued to the reporting person on deferred stock units held by the reporting person"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Grant, award, or other acquisition regulatory

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Brian M. DelGhiaccio?

Aramark reported that director Brian M. DelGhiaccio received 36.644 common stock-equivalent dividend rights. These accrued on deferred stock units he holds, reflecting Aramark’s quarterly dividend, and were granted at no cash cost as additional compensation.

How many Aramark (ARMK) shares does Brian M. DelGhiaccio hold after this Form 4?

After this transaction, Brian M. DelGhiaccio is reported as directly holding 16,385.995 shares of Aramark common stock. This figure includes the newly accrued 36.644 dividend equivalent rights linked to his existing deferred stock unit awards.

What are dividend equivalent rights in the Aramark (ARMK) Form 4 filing?

Dividend equivalent rights are additional stock-linked units that accrue when Aramark pays its quarterly dividend. In this filing, they accrued on DelGhiaccio’s deferred stock units and will vest on the same schedule as the underlying deferred stock unit awards.

Was Brian M. DelGhiaccio’s Aramark (ARMK) transaction an open-market stock purchase?

No, the Form 4 identifies the transaction as a grant or award acquisition. The 36.644 shares represent dividend equivalent rights credited on deferred stock units, with a reported price of $0.00 per share rather than an open-market purchase.

Do the Aramark (ARMK) dividend equivalent rights vest immediately for Brian M. DelGhiaccio?

The filing states that the dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards. This means vesting follows the pre-existing timelines of those awards, rather than occurring immediately upon accrual.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 06:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DelGhiaccio Brian M

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		36.644(1)	A	$0	16,385.995	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)